World Wires · story 12545 · unverified · 1 source(s)

Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences

BEDFORD, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to r

Open in the desk

Coverage

• Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences GlobeNewswire: public companies · tier D · clear net · 2026-10-01 11:00 UTC

What this site indexes